Koyfin alternatives
Koyfin is excellent for charts.
If you screen more than you
chart, there is a better fit.
Koyfin Plus is $39/month and built around dashboards and charting. If most of your time is in the screener — not the charts — you are paying for features you rarely use. These alternatives are built screening-first and cover European markets more deeply.
Updated June 2026 · 5 alternatives reviewed
What a screening-first tool gives you over Koyfin
No charting tax
Koyfin is designed around charts and dashboards. ScreenerHero is designed around the screener. You pay for what you use — not for charting infrastructure you open twice a month.
European microcap depth
Koyfin covers large and mid caps globally. European microcaps and illiquid names have coverage gaps. ScreenerHero includes all European exchanges — microcaps first-class.
Lower price
Koyfin Plus is $39/month. ScreenerHero Pro is €29/month — $10 less for a tool that is screening-first rather than charting-first.
Free core screener
ScreenerHero's core screener is free with no account required. Test the coverage and filter depth before committing to Pro.
What to look for in a Koyfin alternative
Screener as the primary product
Is screening the core of the tool, or a secondary feature added to a charting or dashboard platform?
European microcap fundamental data
P/E, ROE, EV/EBITDA for European small and microcap names — are they populated, or is the EU coverage limited to large caps?
Price relative to workflow
If you rarely use charts, you should not be paying $39/month for charting infrastructure. Match the cost to your actual workflow.
Filter depth
Can you combine 40+ fundamental filters freely across all markets, or does the plan gate certain columns?
Dense output
Results should be a dense, sortable table you can scan in seconds — not dashboards, not cards.
The 5 best Koyfin alternatives for screening (2026)
ScreenerHero
Screening-first. US + Canada + all of Europe. $10 less than Koyfin Plus.
ScreenerHero is screening-first — the screener is the product, not a feature tab. Filter by fundamentals across US, Canadian, and all European equities including microcaps. Pro is €29/month — $10 less than Koyfin Plus, with better European microcap coverage and no charting tax. Free core screener with no account required.
Markets
US, Canada, BME, Euronext Paris, XETRA, Borsa Italiana — all European exchanges
Screener filters
P/E, P/B, ROE, EV/EBITDA, margins, beta, momentum, dividend yield
UI style
Desktop-first, data-dense, built around the screener
Heatmap
Yes
Finviz
The benchmark for dense US screening — no meaningful European coverage
The reference standard for dense, fast screener UX. Finviz Elite is $39.50/month — more than Koyfin Plus and more than ScreenerHero — but covers US equities only. If you screen US names and want maximum density, Finviz is the benchmark. For European coverage, look elsewhere.
Markets
US primarily
Screener filters
P/E, P/B, ROE, margins, momentum — US equities only
UI style
Desktop-first, data-dense, screener-first
Heatmap
Yes
Stockopedia
Score-driven research for European equities — expensive, no US
StockRanks is a respected quality/value/momentum composite, useful for UK equities. No Canadian equities. Continental European microcap coverage has gaps. At €60–80/month it is 2–2.7× more expensive than ScreenerHero for narrower coverage.
Markets
UK-weighted, some continental Europe (no Canada)
Screener filters
StockRanks composite (QVM) + custom filters
UI style
Card-based, research-oriented
Heatmap
No
TIKR
Broad global coverage, loyal user base — EU microcap depth is limited
TIKR Plus is priced aggressively at $10–15/month with broad global coverage. European microcap and illiquid stock coverage is a known gap. TIKR Pro runs $40–55/month — more expensive than Koyfin Plus for a less polished experience.
Markets
100k+ stocks, 92 countries
Screener filters
Fundamentals, historical financials, transcripts on Pro
UI style
Data-focused, less dense UI
Heatmap
No
MarketScreener
Deep European data, news-first, screener is secondary
Broadest European fundamental database available. The product is built around analyst consensus and news — screening is secondary and the interface is dated. Cheaper than Koyfin Plus but not a screener-first alternative.
Markets
Europe and global
Screener filters
300–600 filters including analyst estimates
UI style
Table-based, slow, built around analyst reports
Heatmap
No
Quick comparison
| ScreenerHero | Finviz | Stockopedia | TIKR | MarketScreener | |
|---|---|---|---|---|---|
| US coverage | |||||
| Canadian coverage | |||||
| European coverage | |||||
| Microcap EU coverage | |||||
| Screener-first UX | |||||
| Dense table UI | |||||
| Heatmap | |||||
| Free core features | |||||
| No account required | |||||
| Price/mo (from) | €29 | $39.50 | €60 | $10 | $30 |
Recommendation by use case
You screen more than you chart, across US, Canada, and European markets
ScreenerHero — €29/mo, screening-first, full EU microcap depth, free core screener.
You use charts and screening in equal measure
Koyfin — the charting is genuinely excellent; accept the $39/month and the screener as secondary.
You screen US stocks only and want maximum UI density
Finviz — the benchmark for dense US screening, at $39.50/month.
You prefer composite QVM scores over raw filter sliders
Stockopedia — well-regarded for UK equities, accept the €60–80/month and coverage limits.
You want the broadest global coverage at the lowest price
TIKR Plus — $10–15/month, wide reach, accept European microcap gaps.
$10 less than Koyfin. Built for screening.
Dense tables. Fast filters. Heatmap. US, Canadian, and European equities — including microcaps — in one screening-first tool. Free, no account needed. Pro at €29/month.